HIGHLIGHTS
- What: The PMOA is defined as the single mode of action that contributes most to the overall intended therapeutic effects of the CP. The primary reason for FDA review of medical products is determining whether they are safe and effective for their intended therapeutic purpose.
- Who: Manav V. Singh from the (UNIVERSITY) have published the Article: US regulatory compliance for medical combination products: an overview, in the Journal: (JOURNAL) of August/14,/2024
- Future: This article provides an overview of regulatory review and approval processes for CPs in the the authors including how . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.